Prostate cancer decisions — 2026

The Veteran's service connection claims for headaches, prostate cancer, heart disease, erectile dysfunction (ED), and hypertension have been granted on a direct basis. Effective dates of November 7, 2019, are assigned for prostate cancer, heart disease, ED, and SMC(k); and effective dates of September 23, 2020, are assigned for headaches and hypertension.

The Board dismissed the appeal of a proposed reduction in the evaluation for service-connected prostate cancer with erectile dysfunction from 100 percent to non-compensable, as the August 2025 rating decision was not a final decision and did not effectuate a reduction.

The Veteran's claims for earlier effective dates for service connection for prostate cancer, erectile dysfunction, and SMC due to loss of use of a creative organ are granted.,The Board also remands the case for further development regarding initial disability ratings for prostate cancer and erectile dysfunction.

The Veteran's initial service connection claims for prostate cancer with erectile dysfunction and diabetes mellitus associated with herbicide exposure were denied as there is no evidence of prior claims.,The Veteran's mid-abdomen scar, hypertension, and diabetic nephropathy have all been denied.

The Board has remanded the claims for prostate cancer, skin cancer, and obstructive sleep apnea due to radiation exposure in service at Camp Irwin. The AOJ is required to obtain updated dose assessments from DTRA and verify all periods of active duty training (ACDUTRA) and inactive duty training (INACDUTRA).

The Veteran's claim for higher SMC based on loss of use of both feet and need for regular aid and attendance was denied as the Board found that assigning separate ratings for these conditions would violate pyramiding rules due to overlapping service-connected disabilities.

The Veteran's claims for service connection for coronary artery disease and atherosclerotic cardiovascular disease, hypertension, prostate cancer, and left ankle disability are granted. The claim for a rating in excess of 10 percent for bilateral hearing loss is denied.

The Board has remanded the Veteran's claims for service connection for skin cancer, high blood pressure, prostate cancer, and irregular heartbeat due to insufficient medical opinions.

The Board has restored the Veteran's prostate cancer rating from 10 percent to 40 percent, finding that the reduction was improper and that there is no evidence of improvement in his condition.

The Board has granted the Veteran's claim for service connection for prostate cancer, finding that his current condition is at least as likely as not related to his military service.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that the evidence did not support a causal link between his prostate cancer and toxic exposures during service. The disability was found to be caused by aging and ongoing testosterone production.

The Veteran's claims for increased ratings and a TDIU are being remanded due to the need for additional examinations and consideration of hormone treatment effects on sexual characteristics.

The Board has dismissed the appeals for service connection of prostate cancer, migraines, and chronic sinusitis due to an impermissible concurrent election.

The Veteran's prostate cancer, congestive heart failure, right shoulder disability, and left knee disability are all granted as service-connected. The Board found that the evidence supported a direct relationship between these conditions and active service.

The Board has granted service connection for prostate cancer, special monthly compensation based on housebound status and need for regular aid and attendance, and DIC. The Veteran's prostate cancer is found to be related to his active-duty service.

The Veteran's entitlement to a rating in excess of 100 percent for prostate and bladder cancer residuals was denied from October 23, 2015, to November 30, 2016. From December 1, 2016, the Veteran was granted a 60 percent rating for his cancer residuals.

The Board dismissed the appeal for bilateral hearing loss. Service connection was granted for prostate cancer, erectile dysfunction as secondary to prostate cancer, lumbar spine pain, and radiculopathy of the right lower extremity.

The Board has remanded the case due to new evidence received within a year of the August 2018 rating decision showing diagnosed prostate cancer, which was relevant to the Veteran's service connection claim. The Board is now required to obtain an opinion on the etiology of the Veteran's diagnosed prostate cancer.

The Board has remanded the Veteran's claims for service connection for myelodysplastic syndrome and prostate cancer due to exposure to fuel, exhaust fumes, solvents, lubricants, and smoke during his military service. The VA will provide additional opinions on whether these conditions are at least as likely as not related to active service.

The Board has decided to remand the case due to incomplete information and need for additional medical opinions regarding the Veteran's prostate cancer. The claim will be reconsidered based on all available evidence.